GlassScriptPhysician profile
Kathleen Robertson
NPI 1538106596
$1,743.82
in general payments reported to CMS, 2019-2025
9 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2021: $27.24 · 2022: $22.38 · 2024: $842 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.44 |
| Education | $325.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $688.35 | 2019-2025 | Pangea, Variax |
| Checkpoint Surgical, INC | $321.61 | 2024 | Checkpoint Stimulators |
| Biopro, INC. | $302.46 | 2024 | Thumb, Mod Thumb |
| Sonex Health, INC. | $158.35 | 2024 | Sx-One Microknife |
| Vertex Pharmaceuticals Incorporated | $92.83 | 2025 | |
| Smith+Nephew, INC. | $89.93 | 2019-2022 | |
| Alafair Biosciences, INC. | $58.84 | 2025 | Versawrap |
| Flower Orthopedics Coporation | $18.08 | 2024 | |
| Arteriocyte Medical Systems, INC. | $13.37 | 2024 | Magellan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.